-
Product Name
Tusamitamab ravtansine (Synonyms: MAYTANSIN-LOADED ANTI-CEACAM5 MAB)
- Documents
-
Description
Anti-CEACAM5 / CEA / CD66e Antibody (Tusamitamab ravtansine)
-
Tested applications
ELISA
-
Species reactivity
Human CEACAM5 / CEA / CD66e
-
Alternative names
MAYTANSIN-LOADED ANTI-CEACAM5 MAB antibody
-
Isotype
IgG1
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
0.1 M Pro-Ac, 20 mM Arg, pH 5.0
-
Storage instructions
-80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
-
Validations
SEC-HPLC
The purity of Anti-CEACAM5 / CEA / CD66e Antibody (tusamitamab ravtansine) is 100%, determined by SEC-HPLC.
ELISA
Immobilized human HER2(23 652) His at 2 ug/mL can bind Anti-CEACAM5 / CEA / CD66e Antibody (Tusamitamab ravtansine), EC50 is 0.003203 ug/mL.
Bioactivity: FACS
Human CEACAM5 / CEA / CD66e HEK293 Cell Line were stained Anti-CEACAM5 / CEA / CD66e Antibody (Tusamitamab ravtansine) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, The EC50 is 0.61 ug/mL.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"